Donor pretreatment as an adjunct to cadaver renal allotransplantation.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006649:Histocompatibility Antigens; D006801:Humans; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D037102:Lectins; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D006649:Histocompatibility Antigens; D037102:Lectins; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone; D008727:Methotrexate